Executive cognitive impairment detected by simple bedside testing is associated with poor glycaemic control in type 2 diabetes

South African Medical Journal

Volumn 97, Issue 11 I, 2007, Pages 1074-1076

  de Wet, Hayley ^a   Levitt, Naomi ^b   Tipping, Brent ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; EDUCATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; POINT OF CARE TESTING; RISK ASSESSMENT; SCREENING TEST;

ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 37349034232     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Biessels GJ, Stakenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74.
2. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes - systemic overview of prospective observational studies. Diabetologia 2005; 48: 2460-2469.
3. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diabetes Res Clin Pract 2000; 50: 203-212.
4. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006; 29: 1794-1799.
5. Royall DR, Lauterbach EC, Cummings JL, et al. Executive control: a review of its promise and challenges for clinical research. J Neuropsychiatry Clin Neurosci 2002; 14: 377-405.
6. Schillerstrom JE, Horton MS, Royall DR. The impact of medical illness on executive function. Psychosomatics 2005; 46: 508-516.
7. Royall DR, Chiodo LK, Polk MJ. An empiric approach to level of care determinations: the importance of executive measures. J Gerontology 2005; 60: 1059-1064.
8. Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Applied Neuropsychology 2002; 9: 187-191.
9. Kuo H-K, Jones RN, Milberg WP, et al. Effect of blood pressure and diabetes on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc 2009; 53: 1154-1161.
10. Qui WQ, Price LL, Hibberd P, et al. Executive dysfunction in homebound older people with diabetes mellitus. J Am Geriatr Soc 2006; 54: 496-501.
11. Royall DR, Cordes JA, Polk M. CLOX: an executive drawing task. J Neurol Neurosurg Psychiatry 1998; 64: 588-594.
12. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999; 14: 167-177.
13. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2005; 28 (suppl 1): S4-36.
14. Kahokehr A, Siegert RJ, Weatherall M. The frequency of executive cognitive impairment in elderly rehabilitation inpatients. J Geriatr Psychiatry Neurol 2004; 17: 68-72.
15. Stokholm JS, Vogel A, Gade A, Waldemar G. The executive interview as a screening test for executive dysfunction in patients with mild dementia. J Am Geriatr Soc 2005; 53: 1577-1581.